Cervical Cancer
-
Opportunity India Desk Jun 22 2022 - 2 min readCervavac, developed by Serum Institute of India(SII) is likely to be the first indigenous qHPV vaccine to be approved in India. GlobalData, a leading data and analytics company, notes that this will not only make the drug more affordable to Indians, but will significantly help addressing the growing number of cervical cancer cases in the ...
-
Opportunity India Desk May 16 2022 - 4 min readThanks to central government’s rigorous efforts to make India self-dependent in pharma research and manufacturing added with continuous support to domestic companies in this direction, India is on the verge of having its own vaccine against one of the most dangerous cancer ailments among women – the cervical cancer. After the completion of second phase ...